Jakarta. The National Food and Drug Monitoring Agency, or BPOM, has responded to the unhealthy food portfolio controversy surrounding the world’s largest fast moving consumer goods company Nestle, by saying the report is unrelated to the products’ quality and safety.
Nestle has found itself in hot water after Financial Times came across an internal company presentation. The document acknowledged that more than 60 percent of its F&B products fail to meet the recognized health norms, according to Financial Times.
The news has raised concerns on whether the Nestle products in Indonesia are safe for consumption. BPOM is also facing pressure left and right —including from the Indonesian Consumer Protection Foundation (YLKI)— to conduct an investigation.
“Regarding the…
